I M Murray-Lyon - Concepedia

Author

I M Murray-Lyon

Also Known As

I M Murray-Lyon, I Murray-Lyon, I. M. MURRAY‐LYON, I. M. Murray-Lyon, I. M. Murray‐Lyon, I. Murray-Lyon, I.M Murray-Lyon, I.M. MURRAY-LYON, I.M. MURRAY‐LYON, I.M. Murray-Lyon

Publications

11.2K

Citations

H-Index

128

Concepts

All Affiliations

Charing Cross Hospital King's College Hospital University College London The Royal Free Hospital Medical Research Council

About

I M Murray-Lyon is an author at Charing Cross Hospital specializing in medicine, hepatology, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	39	10.7K
2	Health Sciences	11	11	660
3	Social Sciences	3	3	78
4	Anesthesia	3	3	123
5	Public Health	2	2	53

I M Murray-Lyon

Publications

11K

Citations

H-Index

Page 1

	Year	Citations
Transection of the oesophagus for bleeding oesophageal varices R. N. H. Pugh, I M Murray-Lyon, J L Dawson, British journal of surgery VaricesEsophagusHepatologyEmergency LigationPatient Safety	1973	7.9K
CONTROLLED TRIAL OF PREDNISONE AND AZATHIOPRINE IN ACTIVE CHRONIC HEPATITIS I M Murray-Lyon, R. Stern, Roger Williams The Lancet HepatologyViral HepatitisLiver PhysiologyMedicineHepatitis	1973	471
CHARCOAL HÆMOPERFUSION IN THE TREATMENT OF FULMINANT HEPATIC FAILURE B G Gazzard, M.J. Weston, I M Murray-Lyon, The Lancet HepatologyLiver PhysiologyHepatotoxicityAcute Liver FailureLiver Disease	1974	269
LIVER DAMAGE FROM LONG-TERM METHYLTESTOSTERONE David Westaby, F.J. Paradinas, Susan Ogle, The Lancet HepatologyMedicineLiver PhysiologyPathologyToxicology	1977	210
Histopathological changes in the liver following a paracetamol overdose: Correlation with clinical and biochemical parameters Bernard Portmann, I C Talbot, D W Day, The Journal of Pathology PathologyParacetamol OverdoseCirrhosisHistopathological ChangesInterlobular Bridging Necrosis	1975	147
Scleroderma and Primary Biliary Cirrhosis I M Murray-Lyon, R. P. H. Thompson, I. D. Ansell BMJ Florid StageHepatologyAutoimmune DiseaseSystemic SclerodermaBiliary Tract	1970	143
INDUCTION OF REMISSION IN HEPATOCELLULAR CARCINOMA WITH DOXORUBICIN Philip J. Johnson, Howard Thomas, Roger Williams, The Lancet HepatologyMedicineLiver PhysiologyPathologyLiver Cancer	1978	134
High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma. F.J. Paradinas, W M Melia, Mark Wilkinson, BMJ ImmunologyPathologyTumor BiologyOncologyFibrolamellar Variant	1982	131
NATURAL HISTORY OF LIVER DISEASE IN CHRONIC HEPATITIS B SURFACE ANTIGEN CARRIERS Luis Viola, John C. Coleman, J L Fluker, The Lancet Hepatitis DAutoimmune DiseaseHepatologyViral HepatitisLiver Physiology	1981	122
PLASMA AND BRAIN TRYPTOPHAN CHANGES IN EXPERIMENTAL ACUTE HEPATIC FAILURE G. Curzon, B. D. Kantamanem, J. E. Winch, Journal of Neurochemistry Brain Tryptophan MetabolismLiver FunctionTryptophan MetabolismHepatotoxicityBrain Injury	1973	119

Page 1